WallStreetZenWallStreetZen

NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CRBP

Based on 2 analysts offering 12 month price targets for Corbus Pharmaceuticals Holdings Inc.
Min Forecast
$46.00+37.31%
Avg Forecast
$52.00+55.22%
Max Forecast
$58.00+73.13%

Should I buy or sell CRBP stock?

Based on 2 analysts offering ratings for Corbus Pharmaceuticals Holdings Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRBP stock forecasts and price targets.

CRBP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-03-06

1 of 1

Forecast return on equity

Is CRBP forecast to generate an efficient return?

Forecast return on assets

Is CRBP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CRBP revenue forecast

What is CRBP's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$84.5M
Avg 2 year Forecast
$244.0M
Avg 3 year Forecast
$482.9M

CRBP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRBP$33.50$52.00+55.22%Strong Buy
MNMD$8.52$38.25+348.94%Strong Buy
AURA$7.08$20.00+182.49%Strong Buy
TCRX$7.29$11.33+55.46%Strong Buy
PGEN$1.40$10.00+614.29%Buy
View Top Biotech Stocks

Corbus Pharmaceuticals Holdings Stock Forecast FAQ

Is Corbus Pharmaceuticals Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CRBP) stock is to Strong Buy CRBP stock.

Out of 2 analysts, 1 (50%) are recommending CRBP as a Strong Buy, 1 (50%) are recommending CRBP as a Buy, 0 (0%) are recommending CRBP as a Hold, 0 (0%) are recommending CRBP as a Sell, and 0 (0%) are recommending CRBP as a Strong Sell.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.

What is CRBP's revenue growth forecast for 2028-2030?

(NASDAQ: CRBP) Corbus Pharmaceuticals Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Corbus Pharmaceuticals Holdings's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast CRBP's revenue for 2028 to be $886,457,764, with the lowest CRBP revenue forecast at $886,457,764, and the highest CRBP revenue forecast at $886,457,764. On average, 1 Wall Street analysts forecast CRBP's revenue for 2029 to be $2,560,528,214, with the lowest CRBP revenue forecast at $2,560,528,214, and the highest CRBP revenue forecast at $2,560,528,214.

In 2030, CRBP is forecast to generate $5,066,911,991 in revenue, with the lowest revenue forecast at $5,066,911,991 and the highest revenue forecast at $5,066,911,991.

What is CRBP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CRBP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CRBP's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CRBP price target, the average CRBP price target is $52.00, with the highest CRBP stock price forecast at $58.00 and the lowest CRBP stock price forecast at $46.00.

On average, Wall Street analysts predict that Corbus Pharmaceuticals Holdings's share price could reach $52.00 by Mar 13, 2025. The average Corbus Pharmaceuticals Holdings stock price prediction forecasts a potential upside of 55.22% from the current CRBP share price of $33.50.

What is CRBP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CRBP) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.